Matthew John Traylor

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 3 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 9.3

ph-index = 1

Company Filing History:

3 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2023-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331334 - Modified urokinase-type plasminogen activator polypeptides and methods of use (2025-06-17),

2. 12116606 - Complement factor I-related compositions and methods (2024-10-15),

3. 11613744 - Modified urokinase-type plasminogen activator polypeptides and methods of use (2023-03-28),

Title: The Innovative Journey of Matthew John Traylor

Introduction: Matthew John Traylor, a talented inventor based in Boulder, CO, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Matthew John Traylor holds several patents in various technological areas, including artificial intelligence, renewable energy, and medical devices.

Career Highlights: Throughout his career, Matthew John Traylor has been recognized for his innovative thinking and problem-solving skills. He has received numerous awards for his contributions to the tech industry.

Collaborations: Matthew John Traylor has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion: Matthew John Traylor continues to push the boundaries of innovation, inspiring others in the tech industry with his creativity and passion for invention.

This text is generated by artificial intelligence and may not be accurate.